Form 8-K - Current report:
SEC Accession No. 0000950170-24-113631
Filing Date
2024-10-09
Accepted
2024-10-09 07:55:13
Documents
46
Period of Report
2024-10-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K clsd-20241009.htm   iXBRL 8-K 44731
2 EX-99.1 clsd-ex99_1.htm EX-99.1 29971
3 EX-99.2 clsd-ex99_2.htm EX-99.2 51805
4 GRAPHIC img172386348_0.jpg GRAPHIC 207513
5 GRAPHIC clsd-ex99_1s1.jpg GRAPHIC 474314
6 GRAPHIC clsd-ex99_1s2.jpg GRAPHIC 833298
7 GRAPHIC clsd-ex99_1s3.jpg GRAPHIC 312184
8 GRAPHIC clsd-ex99_1s4.jpg GRAPHIC 356940
9 GRAPHIC clsd-ex99_1s5.jpg GRAPHIC 479253
10 GRAPHIC clsd-ex99_1s6.jpg GRAPHIC 138374
11 GRAPHIC clsd-ex99_1s7.jpg GRAPHIC 271516
12 GRAPHIC clsd-ex99_1s8.jpg GRAPHIC 397759
13 GRAPHIC clsd-ex99_1s9.jpg GRAPHIC 453205
14 GRAPHIC clsd-ex99_1s10.jpg GRAPHIC 134406
15 GRAPHIC clsd-ex99_1s11.jpg GRAPHIC 378944
16 GRAPHIC clsd-ex99_1s12.jpg GRAPHIC 407606
17 GRAPHIC clsd-ex99_1s13.jpg GRAPHIC 386676
18 GRAPHIC clsd-ex99_1s14.jpg GRAPHIC 307302
19 GRAPHIC clsd-ex99_1s15.jpg GRAPHIC 377858
20 GRAPHIC clsd-ex99_1s16.jpg GRAPHIC 144057
21 GRAPHIC clsd-ex99_1s17.jpg GRAPHIC 485234
22 GRAPHIC clsd-ex99_1s18.jpg GRAPHIC 385320
23 GRAPHIC clsd-ex99_1s19.jpg GRAPHIC 570185
24 GRAPHIC clsd-ex99_1s20.jpg GRAPHIC 141512
25 GRAPHIC clsd-ex99_1s21.jpg GRAPHIC 285724
26 GRAPHIC clsd-ex99_1s22.jpg GRAPHIC 321262
27 GRAPHIC clsd-ex99_1s23.jpg GRAPHIC 351090
28 GRAPHIC clsd-ex99_1s24.jpg GRAPHIC 430968
29 GRAPHIC clsd-ex99_1s25.jpg GRAPHIC 337389
30 GRAPHIC clsd-ex99_1s26.jpg GRAPHIC 356199
31 GRAPHIC clsd-ex99_1s27.jpg GRAPHIC 130735
32 GRAPHIC clsd-ex99_1s28.jpg GRAPHIC 532219
33 GRAPHIC clsd-ex99_1s29.jpg GRAPHIC 121411
34 GRAPHIC clsd-ex99_1s30.jpg GRAPHIC 309277
35 GRAPHIC clsd-ex99_1s31.jpg GRAPHIC 263319
36 GRAPHIC clsd-ex99_1s32.jpg GRAPHIC 423666
  Complete submission text file 0000950170-24-113631.txt   16087281

Data Files

Seq Description Document Type Size
37 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clsd-20241009.xsd EX-101.SCH 24862
48 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20241009_htm.xml XML 4719
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37783 | Film No.: 241361515
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)